Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Eymin

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Oncogene|April 21, 2001
Human ARF binds E2F1 and inhibits its transcriptional activityB Eymin, L Karayan, P Séité, et al.
Cell Death and Differentiation|July 30, 2005
E2F1 induces apoptosis and sensitizes human lung adenocarcinoma cells to death-receptor-mediated apoptosis through specific downregulation of c-FLIP(short)C Salon, B Eymin, O Micheau, et al.
International Journal of Cancer|August 4, 1998
Contribution of the cyclin-dependent kinase inhibitor p27KIP1 to the confluence-dependent resistance of HT29 human colon carcinoma cellsM T Dimanche-Boitrel, O Micheau, A Hammann, et al.
Cell Death and Differentiation|June 25, 1999
Selective inhibition of apoptosis by TPA-induced differentiation of U937 leukemic cellsO Sordet, A Bettaieb, J M Bruey, et al.
International Journal of Cancer|October 9, 1995
Cellular pharmacology of azatoxins (topoisomerase-II and tubulin inhibitors) in P-glycoprotein-positive and -negative cell linesB Eymin, E Solary, S Chevillard, et al.
Oncogene|July 20, 2010
The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivoG Merdzhanova, S Gout, M Keramidas, et al.
Oncogene|September 22, 1999
Caspase-induced proteolysis of the cyclin-dependent kinase inhibitor p27Kip1 mediates its anti-apoptotic activityB Eymin, O Sordet, N Droin, et al.
Cell Death and Differentiation|September 23, 2008
E2F1 controls alternative splicing pattern of genes involved in apoptosis through upregulation of the splicing factor SC35G Merdzhanova, V Edmond, S De Seranno, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Oncogene|April 21, 2001
Human ARF binds E2F1 and inhibits its transcriptional activityB Eymin, L Karayan, P Séité, et al.
Cell Death and Differentiation|July 30, 2005
E2F1 induces apoptosis and sensitizes human lung adenocarcinoma cells to death-receptor-mediated apoptosis through specific downregulation of c-FLIP(short)C Salon, B Eymin, O Micheau, et al.
International Journal of Cancer|August 4, 1998
Contribution of the cyclin-dependent kinase inhibitor p27KIP1 to the confluence-dependent resistance of HT29 human colon carcinoma cellsM T Dimanche-Boitrel, O Micheau, A Hammann, et al.
Cell Death and Differentiation|June 25, 1999
Selective inhibition of apoptosis by TPA-induced differentiation of U937 leukemic cellsO Sordet, A Bettaieb, J M Bruey, et al.
International Journal of Cancer|October 9, 1995
Cellular pharmacology of azatoxins (topoisomerase-II and tubulin inhibitors) in P-glycoprotein-positive and -negative cell linesB Eymin, E Solary, S Chevillard, et al.
Oncogene|July 20, 2010
The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivoG Merdzhanova, S Gout, M Keramidas, et al.
Oncogene|September 22, 1999
Caspase-induced proteolysis of the cyclin-dependent kinase inhibitor p27Kip1 mediates its anti-apoptotic activityB Eymin, O Sordet, N Droin, et al.
Cell Death and Differentiation|September 23, 2008
E2F1 controls alternative splicing pattern of genes involved in apoptosis through upregulation of the splicing factor SC35G Merdzhanova, V Edmond, S De Seranno, et al.
Pageof 3